Merck's Lung Cancer Drug Combo Fails Trial

Merck said on Thursday a combination treatment testing a new type of immunotherapy failed to significantly slow disease progression in lung cancer patients who did not respond to previous treatments.

Related Keywords

Bengaluru ,Karnataka ,India ,Mohit Bansal ,Khushi Mandowara ,Devika Syamnath ,Reuters ,Wells Fargo ,Gilead Sciences ,Arcus Bioscience ,Lung Cancer ,Ung Carcinoma ,Ancer Of The Lung ,Small Cell Lung Cancer ,At Cell Lung Cancer ,Clc ,Biologic Therapy ,Iologics ,Immunotherapy ,